HARROW INC (HROW) — insider trading
Health Care · NASDAQ
HARROW INC (HROW) has 15 reported SEC Form 4 insider transactions in our data, including 4 open-market purchases and 5 open-market sales among the most recent 15 (latest 2026-06-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Graves Adrienne L | Director | Grant / award / vesting (derivative) | 5,248 | $0.00 | $0 | Form 4 |
| 2026-06-18 | SILVERNAIL LAUREN P | Director | Grant / award / vesting (derivative) | 5,248 | $0.00 | $0 | Form 4 |
| 2026-06-18 | Sternberg Perry J. | Director | Grant / award / vesting (derivative) | 5,248 | $0.00 | $0 | Form 4 |
| 2026-05-18 | SILVERNAIL LAUREN P | Director | Open-market purchase | 1,000 | $31.00 | $31.0K | Form 4 |
| 2026-05-18 | Graves Adrienne L | Director | Open-market purchase | 1,000 | $31.07 | $31.1K | Form 4 |
| 2026-05-15 | Shojaei Amir | Officer (CHIEF SCIENTIFIC OFFICER) | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-05-14 | BOLL ANDREW R. | Officer (PRESIDENT AND CFO) | Open-market purchase | 3,500 | $29.90 | $104.7K | Form 4 |
| 2026-05-14 | BAUM MARK L | Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market purchase | 10,000 | $30.20 | $302.0K | Form 4 |
| 2026-03-04 | Opaleye Management Inc. | 10% owner | Open-market sale | 4,263 | $39.67 | $169.1K | Form 4 |
| 2026-03-04 | Opaleye Management Inc. | 10% owner | Open-market sale | 134,000 | $39.67 | $5.32M | Form 4 |
| 2026-03-03 | Opaleye Management Inc. | 10% owner | Open-market sale | 1,309 | $39.15 | $51.3K | Form 4 |
| 2026-03-03 | Opaleye Management Inc. | 10% owner | Open-market sale | 59,000 | $39.15 | $2.31M | Form 4 |
| 2026-02-27 | Opaleye Management Inc. | 10% owner | Open-market sale | 5,000 | $54.18 | $270.9K | Form 4 |
| 2026-01-30 | Sullivan Patrick William | Officer (CHIEF COMMERCIAL OFFICER) | Grant / award / vesting (derivative) | 15,000 | $0.00 | $0 | Form 4 |
| 2026-01-30 | Sullivan Patrick William | Officer (CHIEF COMMERCIAL OFFICER) | Grant / award / vesting (derivative) | 25,000 | $0.00 | $0 | Form 4 |
Ask the chat about HROW's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: HARROW INC (HROW).
Last updated 2026-06-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.